Techdamentals
COR · Cencora, Inc.Healthcare

What is Cencora (COR) stock worth?

Its intrinsic value, worked out four ways from Cencora’s own reported numbers, against today’s price.
Fair value range
$424 – $518

Today’s price, $341, sits below the range. 27.6% below the $471.16 the four methods put it at.

UNDERVALUED
After hours $338.67 ▼ 0.76% (not used in the valuation)
This range was worked out on November 12, 2026 from the company's reported numbers. The price is live, and the verdict compares today's price with that range.
A fair value isn’t a one-time number. The valuation methods run on COR’s reported numbers, which change with every quarterly earnings report, and this range is worked out again at least once a month. The price moves every day. So a stock that reads as cheap today can read as fair, or expensive, a few weeks from now. A free account keeps the latest range in front of you, and a phone alert tells you when the price moves into a part of the range you pick.

Inside COR’s full analysis

The real sections, opened with your free account.

Why this verdict Free account

The 4 methods put Cencora’s fair value around $471 a share.

The 4 methods, side by side Free account
Method 1
Method 2
Method 3
Method 4
The business, in plain English Free account
  • Is it growing?
  • Does it make money?
  • Does it bring in cash?
  • Can it pay its bills?
  • What you pay for it

COR’s latest earningsCencora, Inc.

Latest report: July to September 2026 (quarter ended Sep 30, 2026), reported Nov 4, 2026 before the open.

Earnings per share
$4.66In line
$4.57 expected
Stock after report
+4.0%
S&P 500 +1.6%
Next report
Feb 3, 2027
expected date
April to June 2026, in numbers

The full statements for July to September 2026 are not in yet. The numbers below are for April to June 2026 (quarter ended Jun 30, 2026).

Revenue
$85 billion, up 5% from a year ago and up 8% from the quarter before.
Profit
$764 million. It keeps 1¢ of every sales dollar as profit.

From the company's quarterly statements through Jun 30, 2026.

What the company expects next, in its own words
Fiscal 2027 Adjusted Diluted EPS Expected to be in the Range of $19.40 to $19.75, reflecting growth of 8 percent to 10 percent

From the earnings release filed Nov 4, 2026.

The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how COR moved after its last eight reports.

See COR’s full earnings read, free →
Not COR? Value the stock you care about:
Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.